Bay Area's Pionyr Immunotherapeutics Scores $62M to Push Anti-Tumor Tech Towards Clinic Post author:Sam Post published:December 12, 2017 Post category:BioPharma Pionyr was founded in 2015 by a UCSF professor and a Genentech alum. Source: BioSpace You Might Also Like Kalytera Therapeutics Announces Changes To Its Board Of Directors May 25, 2017 BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017 Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial February 7, 2018
BiologicTx Announces First Year International Transplantation Successes Utilizing Matchgrid May 1, 2017
